The Association Between BRAF Mutation Class and Clinical Features in BRAF-Mutant Chinese Non-Small Cell Lung Cancer Patients

被引:0
|
作者
Lin, Q. [1 ]
Zhu, H. [2 ]
Li, Y. [1 ]
Zhang, H. [3 ]
Ding, H. [4 ]
Qian, J. [5 ]
Han-Zhang, H. [6 ]
Lin, J. [6 ]
Xiang, J. [6 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, Wenzhou, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China
[3] Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Peoples R China
[4] Ningbo Diagnost Pathol Ctr, Ningbo, Zhejiang, Peoples R China
[5] Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou, Peoples R China
[6] Burning Rock Biotech, Guangzhou, Guangdong, Peoples R China
关键词
Chinese; braf; NSCLC;
D O I
10.1016/j.jtho.2019.08.735
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.01-20
引用
收藏
页码:S363 / S363
页数:1
相关论文
共 50 条
  • [1] The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients
    Quan Lin
    Haoran Zhang
    Huaxin Ding
    Jun Qian
    Analyn Lizaso
    Jing Lin
    Han Han-Zhang
    Jianxing Xiang
    Yuping Li
    Hong Zhu
    Journal of Translational Medicine, 17
  • [2] The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients
    Lin, Quan
    Zhang, Haoran
    Ding, Huaxin
    Qian, Jun
    Lizaso, Analyn
    Lin, Jing
    Han Han-Zhang
    Xiang, Jianxing
    Li, Yuping
    Zhu, Hong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (01)
  • [3] The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients.
    Zhu, Hong
    Lin, Quan
    Li, Yuping
    Zhang, Haoran
    Ding, Huaxin
    Han Han-Zhang
    Lin, Jing
    Xiang, Jianxing
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Imaging characteristics of BRAF-mutant non-small cell lung cancer by functional class
    Mendoza, Dexter P.
    Dagogo-Jack, Ibiayi
    Chen, Tianqi
    Padole, Atul
    Shepard, Jo-Anne O.
    Shaw, Alice T.
    Digumarthy, Subba Rao
    LUNG CANCER, 2019, 129 : 80 - 84
  • [5] Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer
    Dagogo-Jack, Ibiayi
    Martinez, Pablo
    Yeap, Beow Y.
    Ambrogio, Chiara
    Ferris, Lorin A.
    Lydon, Christine
    Nguyen, Tom
    Jessop, Nicholas A.
    Iafrate, A. John
    Johnson, Bruce E.
    Lennerz, Jochen K.
    Shaw, Alice T.
    Awad, Mark M.
    CLINICAL CANCER RESEARCH, 2019, 25 (01) : 158 - 165
  • [6] BRAF-mutant non-small cell lung cancer (NSCLC): Patient (pt) characteristics and outcomes by class of mutation.
    Dagogo-Jack, Ibiayi
    Martinez, Pablo
    Yeap, Beow Y.
    Ambrogio, Chiara
    Lydon, Christine A.
    Nguyen, Tom
    Iafrate, A. John
    Lennerz, Jochen K.
    Johnson, Bruce E.
    Shaw, Alice Tsang
    Awad, Mark M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Mutation Profile of BRAF in Chinese Non-Small Cell Lung Cancer Patients
    Ai, X.
    Li, Y.
    Chen, R.
    Gu, D.
    Mao, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1149 - S1149
  • [8] BRAF mutant non-small cell lung cancer and treatment with BRAF inhibitors
    Miguel Sanchez-Torres, Jose
    Viteri, Santiago
    Angel Molina, Miguel
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (03) : 244 - 250
  • [9] Understanding BRAF mutation in non-small cell lung cancer patients
    Tine, Mariaenrica
    Squarzoni, Giulia
    Ortolan, Davide
    Pezzuto, Federica
    Calabrese, Fiorella
    Squarzoni, Giulia
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [10] Targeting BRAF-mutant non-small cell lung cancer: Current status and future directions
    Riudavets, Mariona
    Cascetta, Priscilla
    Planchard, David
    LUNG CANCER, 2022, 169 : 102 - 114